Mikko Niemi
Mikko Niemi publishes mostly in Oncology, Pharmacology and Cardiology and Cardiovascular Medicine, on topics such as Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism and Pharmacological Effects and Toxicity Studies.
- World rank
- #98,839 of 7,710,434 ranked researchers
- Rank in Finland
- #505 of 37,370
- Works
- 375
- Citations
- 24k
- Citations per work
- 65.2
What does Mikko Niemi research?
Mikko Niemi's work is mostly in Medicine (30%), Pharmacology, Toxicology and Pharmaceutics (12%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else19652.4%
- Health Sciences11229.8%
- Medicine11229.8%
- Life Sciences6717.8%
- 1Oncology13% of their works
- 2Pharmacology12% of their works
- 3Cardiology and Cardiovascular Medicine7% of their works
- 4Molecular Biology6% of their works
- 5Surgery5% of their works
- 6Endocrinology, Diabetes and Metabolism5% of their works
Research topics
- Drug Transport and Resistance Mechanisms
- Pharmacogenetics and Drug Metabolism
- Pharmacological Effects and Toxicity Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Lipoproteins and Cardiovascular Health
- Diabetes Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Inflammatory mediators and NSAID effects
Which keywords describe Mikko Niemi's research?
The keywords of their largest research topics: ATP-dependent Transporters, Multidrug Resistance, Cytochrome P450, Pharmacogenetics, Antiepileptic Drugs, Prenatal Exposure, Aspirin and Clopidogrel.
- Inflammation
- Atrial Fibrillation
- Type 2 Diabetes
- Statins
- Clopidogrel
- Prenatal Exposure
- Pharmacogenetics
- Multidrug Resistance
- ATP-dependent Transporters
- Cytochrome P450
- Antiepileptic Drugs
- Aspirin
- Cholesterol-lowering
- Cardiovascular Outcomes
- Anticoagulant Therapy
- Cyclooxygenase-2 Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- ATP-dependent Transporters1161 topic
- Multidrug Resistance1161 topic
- Cytochrome P4501121 topic
- Pharmacogenetics1121 topic
- Antiepileptic Drugs291 topic
- Prenatal Exposure291 topic
- Aspirin281 topic
- Clopidogrel281 topic
- Cholesterol-lowering271 topic
- Statins271 topic
- Cardiovascular Outcomes241 topic
- Type 2 Diabetes241 topic
- Anticoagulant Therapy221 topic
- Atrial Fibrillation221 topic
- Cyclooxygenase-2 Inhibitors201 topic
- Inflammation201 topic
Where does Mikko Niemi work?
Mikko Niemi's main affiliation in the publication record is University of Helsinki, Finland.
How many publications and citations does Mikko Niemi have?
OpenAlex counts 375 works and 24,443 citations for Mikko Niemi, an h-index of 74, ranking #98,839 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Mikko Niemi
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mikko Niemi. Posts are plain text and can be reported.